APPLICATION
BLA761451
TYPE
BLA
ORIGINAL APPROVAL
2026-04-24
LATEST ACTION
2026-04-24
ROUTE
SUBCUTANEOUS, SINGLE-USE
DOSAGE FORM
INJECTION, VIAL
MARKETING STATUS
Prescription
Products
SAPHNELOPrescription
ANIFROLUMAB-FNIA 120MG/0.8ML · INJECTION
SAPHNELOPrescription
ANIFROLUMAB-FNIA 300MG/2ML (150MG/ML · VIAL · SINGLE-USE
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.